- A self-guided online cognitive behavioral therapy program for atopic dermatitis was noninferior to clinician-guided treatment in a new randomized clinical trial.
- The self-guided intervention required substantially less clinician time and achieved similar improvements in quality of life, sleep, depression symptoms, itching sensation, and stress levels.
- Lead study author Dorian Kern, PhD, suggested that this treatment offers promise for disseminating evidence-based psychological treatment for patients with atopic dermatitis.
- Study limitations included high data loss for secondary measurements and a predominantly female sample.
- The study was supported by the Swedish Ministry of Health and Social Affairs and registered at ClinicalTrials.gov (NCT05517850).
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
